BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 30/06/2022

FDA Clears MICRONOR for Approval of Norethindrone Tablets

The FDA has determined that MICRONOR (norethindrone tablets, 0.35 mg) was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of norethindrone tablets, 0.35 mg, through abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →